Riskpilot← Back to searchSign inGet full accessWL-Medical Oy
OYDissolvedY-tunnus 0753031-1Metsäläntie 20Wholesale of pharmaceutical and medical goods · NACE 4646Est. 1989— employeeswww.wl-medical.fi
Revenue 2024
EUR 0
EBITDA margin
—
+47% vs 2023
Equity ratio
99.6%
Financial strength
Net profit 2024
EUR 42K
+1426% vs 2023
| Revenue | EUR 0 | — |
| EBITDA | EUR -934 | +47% |
| Net profit | EUR 42K | +1426% |
| Total assets | EUR 2,3M | +0% |
| Equity | EUR 2,3M | +2% |
| Employees | — | — |
Legal name
WL-Medical Oy
Y-tunnus number
0753031-1
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
15. elokuuta 1989
Share capital
EUR 15 938
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-08-31
Financial year
January – December
Signatory rights
Hallituksen jäsen ja toimitusjohtaja yhdessä sekä hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on lääkintälaitteiden ja -tuotteiden ja laboratoriolaitteiden ja -tarvikkeiden valmistus, myynti, huolto, maahantuonti sekä näihin liittyvä konsultointi ja lääkkeiden, lääketarvikkeiden ja terveystuotteiden välitys, agentuuritoiminta ja kauppa. Yhtiö voi toimintaansa varten omistaa osakkeita sekä kiinteätä ja muuta omaisuutta ja lisäksi käydä arvopaperikauppaa.
Address
Metsäläntie 20
Phone
+3580467146850
Email
etunimi.sukunimi@wl-medical.fi
Website
www.wl-medical.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | −0 | −0 |
| EBITDA | −0 | −0 | −0 | −2 | −1 |
| Depreciation & amort. | — | — | — | −0 | −0 |
| EBIT | −0 | −0 | −0 | −2 | −1 |
| Net financials | 28 | 27 | 11 | 65 | 53 |
| Profit before tax | 10 | 9 | 4 | 123 | 52 |
| Tax | 6 | 5 | 2 | 1 | 10 |
| Net profit | 4 | 4 | 2 | 3 | 42 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 226 | 2 228 | 2 217 | 2 272 | 2 263 |
| Equity | 2 203 | 2 206 | 2 209 | 2 211 | 2 253 |
| Long-term debt | — | — | — | 0 | 0 |
| Short-term debt | 23 | 22 | 8 | 60 | 0 |
| Total debt | 23 | 22 | 8 | 61 | 10 |
EBITDA margin
-93400.0%
This company
15.8%
Market median
-591239% vs market
20202024
Equity ratio
99.6%
This company
38.2%
Market median
+161% vs market
20202024
Return on equity
1.8%
This company
18.4%
Market median
-90% vs market
20202024
Net profit margin
4150500.0%
This company
8.1%
Market median
+51240641% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-08-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HM Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (4) | ||
TT Person with significant control | Person with significant control | 2018 – 2019 |
AJ Audit | Audit | 2019 – 2023 |
MO Chief Executive Officer | Chief Executive Officer | 2011 – 2024 |
KP Audit | Audit | 2018 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Former (3) | ||
| Board of Directors | 2018 – 2019 | |
| Board of Directors | 2019 – 2022 | |
| Chairperson | 2018 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OneMed Group Oy
WL-Medical Oy Board members of WL-Medical Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tiia Terhikki Räisänen | Person with significant control | 0 companies |
| Anders Johan Svennas | Audit | 0 companies |
| Markus Oskari Henriksson | Chief Executive Officer | 0 companies |
| Kari Pekka Ruskola | Audit | 0 companies |
| Hanna-Leena Merikanto | Chief Executive Officer | 0 companies |
| Eini Hannele Tiihonen | Board of Directors | 0 companies |
| Lars Olof Ragnar Ingman | Board of Directors | 0 companies |
| Thomas Philip Moss | Board of Directors | 0 companies |
| Carl Johan Falk | Chairperson | 0 companies |
| Juha Pekka Kallioniemi | Board of Directors | 0 companies |